UBS AG Trims Validus Holdings, Ltd. (VR) Target Price to $50.00
Validus Holdings, Ltd. (NYSE:VR) had its target price reduced by equities researchers at UBS AG from $57.00 to $50.00 in a research report issued to clients and investors on Tuesday, www.benzinga.com reports. The firm presently has a “neutral” rating on the insurance provider’s stock. UBS AG’s target price would suggest a potential upside of 8.13% from the company’s previous close.
A number of other equities research analysts also recently issued reports on the company. Zacks Investment Research upgraded Validus Holdings from a “sell” rating to a “hold” rating in a research report on Tuesday, June 20th. ValuEngine upgraded Validus Holdings from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. BidaskClub upgraded Validus Holdings from a “strong sell” rating to a “sell” rating in a research report on Wednesday, June 14th. Buckingham Research started coverage on Validus Holdings in a research report on Monday, September 11th. They set a “buy” rating and a $52.00 price objective on the stock. Finally, Keefe, Bruyette & Woods set a $55.00 price objective on Validus Holdings and gave the company a “hold” rating in a research report on Thursday, August 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $56.29.
Validus Holdings (VR) opened at 46.24 on Tuesday. The company has a market capitalization of $3.67 billion, a price-to-earnings ratio of 12.75 and a beta of 0.65. Validus Holdings has a 52-week low of $41.15 and a 52-week high of $58.76. The company’s 50-day moving average price is $50.75 and its 200 day moving average price is $53.31.
Validus Holdings (NYSE:VR) last issued its quarterly earnings data on Thursday, July 27th. The insurance provider reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.99 by $0.10. Validus Holdings had a return on equity of 7.75% and a net margin of 11.81%. The business had revenue of $675.27 million for the quarter, compared to the consensus estimate of $922.84 million. During the same period in the prior year, the business posted $0.66 earnings per share. On average, equities analysts expect that Validus Holdings will post $3.54 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: This article was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/09/19/ubs-ag-trims-validus-holdings-ltd-vr-target-price-to-50-00.html.
Hedge funds and other institutional investors have recently modified their holdings of the company. IFP Advisors Inc raised its holdings in shares of Validus Holdings by 14.0% in the second quarter. IFP Advisors Inc now owns 2,154 shares of the insurance provider’s stock worth $112,000 after buying an additional 265 shares during the period. SG Americas Securities LLC purchased a new stake in shares of Validus Holdings in the second quarter worth approximately $116,000. The Manufacturers Life Insurance Company raised its holdings in shares of Validus Holdings by 10.1% in the second quarter. The Manufacturers Life Insurance Company now owns 2,382 shares of the insurance provider’s stock worth $124,000 after buying an additional 219 shares during the period. BNP Paribas Arbitrage SA raised its holdings in shares of Validus Holdings by 93.7% in the second quarter. BNP Paribas Arbitrage SA now owns 2,650 shares of the insurance provider’s stock worth $138,000 after buying an additional 1,282 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Validus Holdings by 10.6% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,905 shares of the insurance provider’s stock worth $151,000 after buying an additional 278 shares during the period. Hedge funds and other institutional investors own 93.51% of the company’s stock.
About Validus Holdings
Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.
Receive News & Ratings for Validus Holdings Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus Holdings Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.